InMed Pharmaceuticals Inc expected to post a loss of 23  cents a share - Earnings Preview

InMed Pharmaceuticals

07/02/2022 15:56

* InMed Pharmaceuticals Inc  INM.OQ   INM.O  is expected
to show a
rise in quarterly revenue when it reports  results on February 9
(estimated). 
    * The Vancouver British Columbia-based  company is expected
to
report revenue of $125 thousand, according to the mean estimate
from 2 analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for InMed
Pharmaceuticals Inc
is for a loss of 23 cents per share. For the same quarter last
year, the company reported a loss of 41 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for InMed
Pharmaceuticals Inc is $6.75​, about 82.8% above​ its last
closing price of $1.16. ​​​

This summary was machine generated February 7 at 15:56 GMT.  All
figures in US dollars  unless otherwise stated